56705-87-4 Usage
General Description
N-[3-(4-aminophenoxy)phenyl]-N,N-dimethylamine is a chemical compound that belongs to the family of arylamines. It is a tertiary amine with the molecular formula C16H20N2O. N-[3-(4-AMINOPHENOXY)PHENYL]-N,N-DIMETHYLAMINE is primarily used as an intermediate in the synthesis of pharmaceuticals and organic compounds. It has a wide range of applications, including being used as a reactant in the production of dyes, optical brighteners, and other chemicals. N-[3-(4-aminophenoxy)phenyl]-N,N-dimethylamine is considered to be a versatile and valuable compound in the field of organic chemistry due to its reactive nature and its ability to participate in various chemical reactions.
Check Digit Verification of cas no
The CAS Registry Mumber 56705-87-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,6,7,0 and 5 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 56705-87:
(7*5)+(6*6)+(5*7)+(4*0)+(3*5)+(2*8)+(1*7)=144
144 % 10 = 4
So 56705-87-4 is a valid CAS Registry Number.
56705-87-4Relevant articles and documents
Derivatives of quinoline as inhibitors for MEK
-
Page/Page column 61, (2010/02/14)
1. A compound of formula (I) or a pharmaceutically acceptable salt thereof. wherein: n is 0-1; X and Y are independently selected from -NH-, -O-, -S-, or -NR8- where R8 is alkyl of 1-6 carbon atoms and X may additionally comprise a CH2 group; R7 is a group (CH2)mR9 where m is 0,or an integer of from 1-3 and R9 is a substituted aryl group, an optionally substituted cycloalkyl ring of up to 10 carbon atoms, or an optionally substituted heterocyclic ring or an N-oxide of any nitrogen containing ring; R6 is a divalent cycloalkyl of 3 to 7 carbon atoms, which may be optionally further substituted with one or more alkyl of 1 to 6 carbon atom groups; or is a divalent pyridinyl, pyimidinyl, or phenyl ring; wherein the pyridinyl, pyrimidinyl, or phenyl ring may be optionally further substituted with one or more specified groups; R1, R2, R3 and R4 are each independently selected from hydrogen or various specified organic groups. Compounds are useful as pharmaceuticals for the inhibition of MEK activity.
